India's Ministry of Health Approves ThermoGenesis' (KOOL) AutoXpress System
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Join SI Premium – FREE
ThermoGenesis Corp. (NASDAQ: KOOL) announced today that India's Ministry of Health has approved the AutoXpress® System, enabling the Company to initiate commercial sales of the product in India. The AXP is used for the processing of stem cells from cord blood.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Solowin Holdings marks 10 years, expands into stablecoins and AI
- Nu Skin EVP of global sales takes medical leave
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
